JPRN-UMIN000051326
Not Yet Recruiting
N/A
A preliminary clinical study to examine the validity of measuring tooth brushing-induced gingival bleeding as a diagnostic method for gingivitis - t-BIGB study
Conditionsgingivitis, periodontal disease
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- gingivitis, periodontal disease
- Sponsor
- Tokushima University
- Enrollment
- 50
- Status
- Not Yet Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Subjects with dental diseases such as caries, periodontal disease, or oral mucosal diseases that require immediate treatment. 2\. When consent to participate cannot be obtained from the research subject (and legally acceptable person). 3\. In addition, when the research director or researcher determines that it is appropriate to stop the research.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
A prospective clinical study to evaluate the feasibility and safeness of the chemotherapy with weekly paclitaxel administration in cases with anaplastic thyroid cancerJPRN-UMIN000008574Anaplastic Thyroid Carcinoma Consortium Japan50
Completed
Phase 1
A Clinical Study to know the safety, pharmacokinetics and anticancer activity of NRC-2694-A in patients with advanced cancersCTRI/2014/01/004293ATCO Pharma Limited26
Completed
N/A
Phase I clinical study to evaluate the safety and tolerability of Quadrivalent Influenza Vaccine (QIV) delivered intradermally by a high-density micro-array patch (HD MAP), compared to intramuscular Influvac® Tetra injection, in healthy adults aged 18 to 50 yearsrespiratory infectionInfluenzaRespiratory - Other respiratory disorders / diseasesACTRN12622001203741Vaxxas Pty Ltd150
Completed
N/A
Phase I clinical study to evaluate the safety and tolerability of SARS-CoV-2 spike protein (HexaPro) delivered intradermally by a high-density microarray patch (HD-MAP), in healthy adults aged 18 to 50 years.SARS-CoV-2 infectionInfection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesACTRN12622000597796Vaxxas Pty Ltd44
Completed
Phase 1
Salmonella vaccine study in OxfordISRCTN51750695niversity of Oxford31